Drawing for RXTECHULATE

USPTO serial 88422661

RXTECHULATE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
AIKENS, RONALD E
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with RXTECHULATE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
010Medical devices for use in treating or diagnosing swallowing disorders and symptoms of dysphagia; Telemetry devices for medical applicationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 2, 2022WOAGWITHDRAWAL OF ATTORNEY GRANTED—
Jan 2, 2022WOARTEAS WITHDRAWAL OF ATTORNEY RECEIVED—
Jun 1, 2021MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 31, 2021ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 29, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 27, 2020EX2GSOU EXTENSION 2 GRANTED—
Oct 27, 2020EXT2SOU EXTENSION 2 FILED—
Oct 27, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 20, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 20, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 20, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 24, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 23, 2020EX1GSOU EXTENSION 1 GRANTED—
Jun 17, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 1, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 29, 2020EXT1SOU EXTENSION 1 FILED—
Oct 29, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 3, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 3, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 14, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 25, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 24, 2019DOCKASSIGNED TO EXAMINER—
May 24, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 13, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance